Skip to content

13F-HR filed by STATE OF WISCONSIN INVESTMENT BOARD

STATE OF WISCONSIN INVESTMENT BOARD filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 1,539 holding rows worth $36,183,164,000.

Accession
0001097241-18-000009
Filed
2018-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 1,539 entries on the cover page, a total value of $36,183,164,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $36,183,175,000 with VALUE read as thousands by filing date, 13F file number 028-02519. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ADT INC DEL COM00090Q103Stock21,181$199,000thousands by filing date
POLARITYTE INC731094108COM10,300$197,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM13,000$193,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK19,000$192,000thousands by filing date
PILGRIMS PRIDE CORP COM72147K108Stock10,240$185,000thousands by filing date
RPC INC749660106COMMON STOCK10,966$170,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM29,000$169,000thousands by filing date
VERACYTE INC COM92337F107Stock17,000$162,000thousands by filing date
ATHERSYS INC04744L106COM75,000$157,000thousands by filing date
BRIDGEWATER BANCSHARES INC108621103COMMON STOCK12,000$156,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity16,000$155,000thousands by filing date
QIWI PLC74735M108SPON ADR REP B11,662$154,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM26,000$146,000thousands by filing date
CORIUM INTL INC21887L107COM15,000$143,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS57,000$134,000thousands by filing date
CHIMERIX INC COM16934W106Stock34,000$132,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM18,000$124,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM20,000$123,000thousands by filing date
TELIGENT INC NEW87960W104COM31,000$122,000thousands by filing date
CALITHERA BIOSCIENCES INC COM NEW13089P101Stock23,000$121,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM15,000$114,000thousands by filing date
AGENUS INC00847G705COM NEW53,000$113,000thousands by filing date
ARDELYX INC039697107COM25,000$109,000thousands by filing date
DURECT CORP266605104COM97,000$107,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM21,000$100,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM15,000$92,000thousands by filing date
ACHAOGEN INC004449104COM22,000$88,000thousands by filing date
ORGANOVO HOLDINGS INC68620A104COMMON75,000$86,000thousands by filing date
SOCIETAL CDMO INC75629F109COM11,000$78,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK28,000$77,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM14,000$68,000thousands by filing date
NANTKWEST INC63016Q102COM17,000$63,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM10,000$56,000thousands by filing date
NYMOX PHARMACEUTICAL CORP ORD SHS CorpP73398102Common Stock22,000$54,000thousands by filing date
NEWLINK GENETICS CORP651511107COM17,000$41,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock12,000$41,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM25,000$40,000thousands by filing date
VITAL THERAPIES INC92847R104COM31,700$9,000thousands by filing date
COMMUNITY HEALTH SYS INC NEW203668116RIGHT 99/99/9999184,263$1,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001097241-18-000009this filing2018-11-14acceptance time not in the bulk data set